These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 3128058)

  • 61. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 63. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 64. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R; Tvede N; Bendixen G
    Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
    [No Abstract]   [Full Text] [Related]  

  • 65. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis.
    Kvien TK; Høyeraal HM; Sandstad B
    Scand J Rheumatol; 1985; 14(4):346-54. PubMed ID: 3936167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
    An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nephrotic syndrome induced by penicillamine.
    Stein J; Smythe HA
    Can Med Assoc J; 1968 Mar; 98(10):505-7. PubMed ID: 5645186
    [No Abstract]   [Full Text] [Related]  

  • 69. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
    Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
    Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
    [No Abstract]   [Full Text] [Related]  

  • 70. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studies on pyrimidine biosynthesis in the granulocytes of patients receiving gold therapy for rheumatoid arthritis.
    Westwick WJ; Allsop J; Gumpel JM; Watts RW
    Q J Med; 1974 Apr; 43(170):231-43. PubMed ID: 4369231
    [No Abstract]   [Full Text] [Related]  

  • 73. [New diagnostic standards in rheumatoid arthritis and recent trends in drug therapy].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):334-7. PubMed ID: 2110235
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Nephrotic syndrome due to penicillamine (author's transl)].
    Henningsen B; Maintz J; Basedow M; Harders H
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1768. PubMed ID: 4742512
    [No Abstract]   [Full Text] [Related]  

  • 76. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

  • 77. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 78. [A case report of rheumatoid arthritis which showed acute renal failure, nephrotic syndrome and drug-related lupus-like syndrome caused by D-penicillamine].
    Suda M; Yoshikawa Y; Suzuki T; Dohi Y; Shibata T
    Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1235-41. PubMed ID: 2082056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low incidence of toxicity from gold thiomalate in Hong Kong Chinese patients with rheumatoid arthritis.
    Cohen MG; Ng PY; Chan KL; Li EK
    J Rheumatol; 1991 Apr; 18(4):630-2. PubMed ID: 1906106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.